SQZ Biotechnologies Price to Free Cash Flow Ratio 2020-2023 | SQZ
Historical price to free cash flow ratio values for SQZ Biotechnologies (SQZ) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| SQZ Biotechnologies Price to Free Cash Flow Ratio Historical Data |
| Date |
Stock Price |
TTM FCF per Share |
Price to FCF Ratio |
| 2023-05-26 |
0.57 |
|
0.00 |
| 2023-03-31 |
0.56 |
$-2.99 |
0.00 |
| 2022-12-31 |
0.74 |
$-2.92 |
0.00 |
| 2022-09-30 |
2.28 |
$-2.96 |
0.00 |
| 2022-06-30 |
3.18 |
$-2.99 |
0.00 |
| 2022-03-31 |
4.81 |
$-2.94 |
0.00 |
| 2021-12-31 |
8.93 |
$-3.00 |
0.00 |
| 2021-09-30 |
14.42 |
$-10.41 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.017B |
$0.021B |
|
SQZ Biotechnologies Company is a clinical-stage biotechnology company. It develops transformative cell therapies for patients with cancer, infectious diseases and other serious conditions. The company's prime product candidate consist SQZ-PBMC-HPV which is in clinical stage. SQZ Biotechnologies Company is based In Watertown, Massachusetts.
|
